ARTICLE
23 April 2019

Influencer Promo Guide: Best Practices For Drug And Device Firms

All companies must be mindful of compliance with Federal Trade Commission (FTC) guidelines for influencers and marketers,
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

All companies must be mindful of compliance with Federal Trade Commission (FTC) guidelines for influencers and marketers, which require, among other things, that ads and endorsements be clearly identified and substantiated and relationships with influencers that include any exchange of value, monetary or otherwise, be clearly disclosed.

Medical device and pharmaceutical companies, however, bear the additional burden of compliance with the detailed and often complex U.S. Food and Drug Administration (FDA) regulations covering labeling and advertising requirements for drugs and medical devices. Regulatory agencies may hold drug and device firms accountable for statements made by social media influencers that they engage to promote their products. How, then, can these companies take advantage of the many benefits of social media influencers, and particularly microinfluencers, without running afoul of the myriad advertising and promotional regulations and requirements for their products?

Read More: Influencer promo guide: Best practices for drug and device firms

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More